130 related articles for article (PubMed ID: 8811458)
21. Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry.
Ji HY; Jeong DW; Kim YH; Kim HH; Yoon YS; Lee KC; Lee HS
Rapid Commun Mass Spectrom; 2006; 20(14):2127-32. PubMed ID: 16773671
[TBL] [Abstract][Full Text] [Related]
22. Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene and its application to a pharmacokinetic study.
Jalalizadeh H; Souri E; Tehrani MB; Jahangiri A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):43-7. PubMed ID: 17517538
[TBL] [Abstract][Full Text] [Related]
23. [LC-MS/MS method for quantification and pharmacokinetic study of gabapentin in human plasma].
Xiong ZL; Yu J; He JF; Qin F; Li FM
Yao Xue Xue Bao; 2011 Oct; 46(10):1246-50. PubMed ID: 22242459
[TBL] [Abstract][Full Text] [Related]
24. Highly sensitive determination and validation of gabapentin in pharmaceutical preparations by HPLC with 4-fluoro-7-nitrobenzofurazan derivatization and fluorescence detection.
Ulu ST; Kel E
J Chromatogr Sci; 2011; 49(6):417-21. PubMed ID: 21682989
[TBL] [Abstract][Full Text] [Related]
25. Procedure for the monitoring of gabapentin with 2,4,6-trinitrobenzene sulfonic acid derivatization followed by HPLC with ultraviolet detection.
Juenke JM; Brown PI; McMillin GA; Urry FM
Clin Chem; 2003 Jul; 49(7):1198-201. PubMed ID: 12816924
[No Abstract] [Full Text] [Related]
26. Rapid quantification of gabapentin in human plasma by liquid chromatography/tandem mass spectrometry.
Ramakrishna NV; Vishwottam KN; Koteshwara M; Manoj S; Santosh M; Chidambara J; Sumatha B; Varma DP
J Pharm Biomed Anal; 2006 Feb; 40(2):360-8. PubMed ID: 16112830
[TBL] [Abstract][Full Text] [Related]
27. Spectrofluorimetric determination of vigabatrin and gabapentin in dosage forms and spiked plasma samples through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.
Hassan EM; Belal F; Al-Deeb OA; Khalil NY
J AOAC Int; 2001; 84(4):1017-24. PubMed ID: 11501899
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma.
Mercolini L; Mandrioli R; Amore M; Raggi MA
J Pharm Biomed Anal; 2010 Sep; 53(1):62-7. PubMed ID: 20363577
[TBL] [Abstract][Full Text] [Related]
29. Validated LC-MS-MS method for the determination of gabapentin in human plasma: application to a bioequivalence study.
Wattananat T; Akarawut W
J Chromatogr Sci; 2009; 47(10):868-71. PubMed ID: 19930796
[TBL] [Abstract][Full Text] [Related]
30. Determination of tianeptine in tablets by high-performance liquid chromatography with fluorescence detection.
Ulu ST
J AOAC Int; 2007; 90(3):720-4. PubMed ID: 17580625
[TBL] [Abstract][Full Text] [Related]
31. Determination of gabapentin in plasma and urine by high-performance liquid chromatography and pre-column labelling for ultraviolet detection.
Hengy H; Kölle EU
J Chromatogr; 1985 Jun; 341(2):473-8. PubMed ID: 4030992
[No Abstract] [Full Text] [Related]
32. Cost-efficient use of gas chromatography-mass spectrometry: a "piggyback" method for analysis of gabapentin.
Van Lente F; Gatautis V
Clin Chem; 1998 Sep; 44(9):2044-5. PubMed ID: 9733003
[No Abstract] [Full Text] [Related]
33. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products.
Ciavarella AB; Gupta A; Sayeed VA; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2007 Apr; 43(5):1647-53. PubMed ID: 17275240
[TBL] [Abstract][Full Text] [Related]
34. Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application.
Yagi T; Naito T; Mino Y; Takashina Y; Umemura K; Kawakami J
J Clin Pharm Ther; 2012 Feb; 37(1):89-94. PubMed ID: 21276028
[TBL] [Abstract][Full Text] [Related]
35. Determination of vigabatrin in plasma by reversed-phase high-performance liquid chromatography.
Tsanaclis LM; Wicks J; Williams J; Richens A
Ther Drug Monit; 1991 May; 13(3):251-3. PubMed ID: 1926280
[TBL] [Abstract][Full Text] [Related]
36. Determination of gabapentin-lactam in serum of patients under gabapentin therapy.
Knörle R; Feuerstein TJ; Schulze-Bonhage A
Arzneimittelforschung; 2004; 54(3):139-42. PubMed ID: 15112859
[TBL] [Abstract][Full Text] [Related]
37. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
[TBL] [Abstract][Full Text] [Related]
38. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.
Stewart BH; Kugler AR; Thompson PR; Bockbrader HN
Pharm Res; 1993 Feb; 10(2):276-81. PubMed ID: 8456077
[TBL] [Abstract][Full Text] [Related]
39. Measurement of a new anticonvulsant, (S)-3-(aminomethyl)-5-methylhexanoic acid, in plasma and milk by high-performance liquid chromatography.
Windsor BL; Radulovic LL
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):143-8. PubMed ID: 8749263
[TBL] [Abstract][Full Text] [Related]
40. Analysis of gabapentin in serum and plasma by solid-phase extraction and gas chromatography-mass spectrometry for therapeutic drug monitoring.
Kushnir MM; Crossett J; Brown PI; Urry FM
J Anal Toxicol; 1999; 23(1):1-6. PubMed ID: 10022201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
